The effect of a slower than standard dose escalation scheme for dipyridamole on headaches in secondary prevention therapy of strokes: A randomized, open-label trial (DOSE)

Cerebrovascular Diseases

Volumn 37, Issue 4, 2014, Pages 285-289

  De Vos Koppelaar, N C Martine ^a   Kerkhoff, Henk ^a   De Vogel, Ed M ^a   Zock, Elles ^a   Dieleman, Hetty G ^a  

^a ALBERT SCHWEITZER HOSPITAL   (Netherlands)

Author keywords

Dipyridamole; Dose escalation; Headache; Stroke

Indexed keywords

ACETYLSALICYLIC ACID; DIPYRIDAMOLE; ANTITHROMBOCYTIC AGENT;

AGED; ARTICLE; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CLINICAL PRACTICE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DOSE ESCALATION; DRUG EFFECT; DRUG INDUCED HEADACHE; DRUG WITHDRAWAL; FEMALE; HUMAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; OPEN STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TRANSIENT ISCHEMIC ATTACK; TREATMENT DURATION; TREATMENT OUTCOME; VISUAL ANALOG SCALE; COMPLICATION; DRUG COMBINATION; HEADACHE; ISCHEMIC ATTACK, TRANSIENT; PROCEDURES; SECONDARY PREVENTION; STROKE; DRUG DOSE COMPARISON; MEDICATION COMPLIANCE; OUTCOME ASSESSMENT; PATIENT COMPLIANCE;

ASPIRIN; DIPYRIDAMOLE; DRUG THERAPY, COMBINATION; FEMALE; HEADACHE; HUMANS; ISCHEMIC ATTACK, TRANSIENT; MALE; PLATELET AGGREGATION INHIBITORS; SECONDARY PREVENTION; STROKE;

EID: 84899780500     PISSN: 10159770     EISSN: 14219786     Source Type: Journal    
DOI: 10.1159/000360751     Document Type: Article

References (10)

1. Diener HC, Cunha L, Forbes C, et al: European Stroke Prevention Study 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. J Neurol Sci 1996; 143: 1-13.
2. The EPRIT Study Group: Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial. Lancet 2006; 367: 1665-1673.
3. Theis JGW, Deichsel G, Marshall S: Rapid development of tolerance to dipyridamole-associated headaches. Br J Clin Pharmacol 1999; 48: 750-755.
4. Lökk J: Dipyridamole-associated headache in stroke patients-interindividual differences? Eur Neurol 2009; 62: 109-113.
5. Chang YJ, Ryu SJ, Lee TH: Dose titration to reduce dipyridamole-related Headache. Cerebrovasc Dis 2006; 22: 258-262.
6. Werkgroep CBO: Richtlijn Beroerte, 2008. Utrecht, Kwaliteitsinstituut voor de Gezondheidszorg CBO, 2008.
7. Lenz TL, Wilson AF: Clinical pharmacokinetics of antiplatelet agents used in the secondary prevention of stroke. Clin Pharmacokinet 2003; 42: 909-920.
8. Halkes PH, Gray LJ, Bath PM, et al: Dipyridamole plus aspirin versus aspirin alone in secondary prevention after TIA or stroke: a meta-analysis by risk. J Neurol Neurosurg Psychiatry 2008; 79: 1218-1223.
9. Lipton RB, Bigal ME, Kolodner KB, et al: Acetominophen in the treatment of headaches associated with dipyridamole-aspirin combination. Neurology 2004; 63: 1099-1101.
10. Douen AG, Medic S, Sabih M, et al: Titrated initiation of acetylsalicylic acid-dipyridamole therapy reduces adverse effects and improves tolerance in patients with stroke. J Stroke Cerebrovasc Dis 2008; 17: 356-359.